<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pain, Sedation & References | Emergency Care Algorithms 2023</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\(', '\)']],
            displayMath: [['$$', '$$'], ['\[', '\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="08-psychiatric-gi-poisoning.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                       <span class="progress-text">Part 9 of 9</span>
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Pain, Sedation & Appendices</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: algo42 -->
                <section id="algo42" class="content-section" aria-labelledby="section-heading-42">
                    <h2 id="section-heading-42" class="section-heading">
                        <span class="heading-text">42. Pain Management Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-70-1.jpg" alt="Pain Management Algorithm flowchart, showing pain assessment using a numerical rating scale and corresponding treatment pathways for mild, moderate, and severe pain." class="content-image">
                        
                        <h4>REGIONAL ANAESTHESIA</h4>
                        <h5>Indications</h5>
                        <ul>
                            <li>Acute pain management for wounds, fractures and dislocations</li>
                            <li>Alternative to procedural sedation</li>
                            <li>Alternative to narcotics in certain patient populations (e.g. head injured patient, patients with concomitant mental status change, patients given buprenorphine)</li>
                        </ul>
                        <h5>Contraindications</h5>
                        <ul>
                            <li>Allergy to local anaesthetic agents</li>
                            <li>Active infection at the site of injection</li>
                            <li>Injuries at risk of compartment syndrome</li>
                            <li>Uncooperative patient</li>
                            <li>Pre-existent neurologic deficit</li>
                            <li>Anticoagulation (relative)</li>
                        </ul>
                        
                        <p><a href="http://www.nysora.com">Watch video on our YouTube Channel</a></p>
                        <h5>Types</h5>
                        <ul>
                           <li>Wrist (Ulnar, Median and Radial nerve) block for the hand</li>
                           <li>Digital nerve blocks for fingers and toes</li>
                           <li>Femoral nerve block for the anterior thigh, femur, knee and skin anaesthesia over the medial aspect of the leg below the knee</li>
                           <li>Facial and dental nerve blocks</li>
                           <li>Ankle blocks for the foot</li>
                           <li>Haematoma blocks</li>
                        </ul>

                        <h5>Anaesthetic - Lidocaine</h5>
                        <ul>
                           <li>Dose - 3 mg/kg</li>
                           <li>Onset of action - &lt; 2 mins</li>
                           <li>Duration - 60 mins</li>
                        </ul>
                    </div>
                </section>
                <!-- END: algo42 -->

                <!-- START: algo43 -->
                <section id="algo43" class="content-section" aria-labelledby="section-heading-43">
                    <h2 id="section-heading-43" class="section-heading">
                        <span class="heading-text">43. Low Back Pain Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-71-1.jpg" alt="Algorithm for managing low back pain, showing initial assessment, screening for red flags, and pathways for non-specific LBP, radiculopathy, or specific spinal causes." class="content-image">

                        <h4>Diagnostic Work-up for Low Back Pain</h4>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Possible cause</th>
                                        <th>Key features on history or physical examination</th>
                                        <th>Imaging*</th>
                                        <th>Additional studies*</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td rowspan="3">Cancer</td>
                                        <td>History of cancer with new onset of LBP</td>
                                        <td>MRI</td>
                                        <td rowspan="3">ESR</td>
                                    </tr>
                                    <tr>
                                        <td>Unexplained weight loss<br>Failure to improve after 1 month<br>Age >50 years</td>
                                        <td>Lumbosacral plain radiography</td>
                                    </tr>
                                    <tr>
                                        <td>Multiple risk factors present</td>
                                        <td>Plain radiography or MRI</td>
                                    </tr>
                                    <tr>
                                        <td>Vertebral infection</td>
                                        <td>Fever<br>Intravenous drug use<br>Recent infection</td>
                                        <td>MRI</td>
                                        <td>ESR and/or CRP</td>
                                    </tr>
                                    <tr>
                                        <td>Cauda equina syndrome</td>
                                        <td>Urinary retention<br>Motor deficits at multiple levels<br>Fecal incontinence<br>Saddle anesthesia</td>
                                        <td>MRI</td>
                                        <td>None</td>
                                    </tr>
                                    <tr>
                                        <td>Vertebral compression fracture</td>
                                        <td>History of osteoporosis<br>Use of corticosteroids<br>Older age</td>
                                        <td>Lumbosacral plain radiography</td>
                                        <td>None</td>
                                    </tr>
                                    <tr>
                                        <td>Ankylosing spondylitis</td>
                                        <td>Morning stiffness<br>Improvement with exercise<br>Alternating buttock pain<br>Awakening due to back pain during the second part of the night<br>Younger age</td>
                                        <td>Anteriorposterior pelvis plain radiography</td>
                                        <td>ESR and/or CRP, HLA-B27</td>
                                    </tr>
                                    <tr>
                                        <td>Severe/ progressive neurologic deficits</td>
                                        <td>Progressive motor weakness</td>
                                        <td>MRI</td>
                                        <td>Consider EMG/NCV</td>
                                    </tr>
                                    <tr>
                                        <td rowspan="2">Herniated disc</td>
                                        <td>Back pain with leg pain in an L4, L5, or S1 nerve root distribution<br>Positive straight-leg-raise test or crossed straight-leg-raise test</td>
                                        <td>None</td>
                                        <td>None</td>
                                    </tr>
                                    <tr>
                                        <td>Symptoms present >1 month</td>
                                        <td>MRI</td>
                                        <td>Consider EMG/NCV</td>
                                    </tr>
                                    <tr>
                                        <td rowspan="2">Spinal stenosis</td>
                                        <td>Radiating leg pain<br>Older age<br>(Pseudoclaudication a weak predictor)</td>
                                        <td>None</td>
                                        <td>None</td>
                                    </tr>
                                    <tr>
                                        <td>Symptoms present >1 month</td>
                                        <td>MRI</td>
                                        <td>Consider EMG/NCV</td>
                                    </tr>
                                </tbody>
                                <tfoot><tr><td colspan="4"><small>*Level of evidence for diagnostic evaluation is variable.</small></td></tr></tfoot>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: algo43 -->
                
                <!-- START: algo44 -->
                <section id="algo44" class="content-section" aria-labelledby="section-heading-44">
                    <h2 id="section-heading-44" class="section-heading">
                        <span class="heading-text">44. Management of Pain in Sickle Cell Disease Algorithm</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-73-1.jpg" alt="Algorithm for managing pain in Sickle Cell Disease, detailing assessment of pain severity, rapid administration of analgesics, hydration, and criteria for admission or discharge." class="content-image">
                        <h4>Investigations:</h4>
                        <p><strong>Full Blood Count (FBC);</strong></p>
                        <ul>
                            <li>Most patients with HbSS disease have a baseline haemoglobin level of 6 to 9 g/dL and tolerate this level of anaemia well because of physiologic adaptations.</li>
                            <li>WBC is NOT a particularly sensitive nor specific indicator for infection</li>
                        </ul>
                        <p><strong>Reticulocyte count</strong> - normally elevated (>5%). Levels < 5% are a serious cause for concern as it signifies bone marrow hypo activity. In patients with worsened scleral icterus, back pain, fever, or signs that suggest haemolysis, additional tests would include; LFTs and LDH</p>
                        <p><strong>Renal function tests</strong></p>
                        <p><strong>Blood typing and screening</strong> is necessary if haemoglobin has dropped >1 mg/dL below baseline or if there is concern that the patient may need a transfusion. Indications for blood transfusion; Severe anaemia - ↓ Hb > 2g/dL below steady state or < 6g/dL; Acute chest syndrome; Priapism; CVA in children; Before surgery</p>
                    </div>
                </section>
                <!-- END: algo44 -->

                <!-- START: algo45 -->
                <section id="algo45" class="content-section" aria-labelledby="section-heading-45">
                    <h2 id="section-heading-45" class="section-heading">
                        <span class="heading-text">45. Procedural Sedation and Analgesia (PSA)</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>SEE THE EMERGENCY DEPARTMENT PROCEDURAL SEDATION AND ANALGESIA PHYSICIAN CHECKLIST</strong></p>
                        <p>Procedural sedation is the technique of administering sedatives or dissociative agents with or without analgesics to induce a state that allows the patient to tolerate unpleasant procedures while maintaining cardiorespiratory function.</p>
                        <p><strong>Potential indications for procedural in the ED:</strong> fracture reduction, joint reduction, incision and drainage, chest tube placement, electro cardioversion, upper endoscopy (with a gastroenterologist), foreign body removal, burn or wound debridement</p>
                        <p><strong>Patient selection:</strong> A pre-procedural history and physical exam, as documented in the ED record, should reflect a focused evaluation of the airway, cardiovascular status, pulmonary status, allergies, and history of prior adverse reactions to sedatives or anaesthetics. PSA may not be ideal for patients with significant chronic morbidities e.g. sleep apnoea, COPD, low baseline oxygen saturations or blood pressure, or anatomic features that would make bag valve mask (BVM) ventilation or maintaining an airway difficult.</p>
                        <p><strong>Preparation:</strong> Monitoring equipment (continuous telemetry, pulse oximetry, BP; consider continuous end tidal CO2 monitoring), peripheral IV, Ringer's Lactate/Hartmann's Solution, medications for PSA, naloxone (if opiates are given), equipment for procedure (e.g. scalpel), team ( minimum one practitioner for sedation, one for procedure ONE OF THEM MUST BE PROFICIENT IN AIRWAY MANAGEMENT), airway equipment (oxygen source, nasal cannula/face mask, BVM, suction), rescue airway equipment (endotracheal tube, laryngoscope, LMA, nasal trumpet)</p>
                        <p><strong>OBTAIN CONSENT for ALL PSA Procedures</strong></p>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Medication for PSA - give both an Analgesic AND a Sedative unless using Ketamine which is both</caption>
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Dosage</th>
                                        <th>Analgesic/ Sedative</th>
                                        <th>Onset/Peak Effect</th>
                                        <th>Duration of Action</th>
                                        <th>Adverse Effects</th>
                                        <th>Comments/Caveats</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Ketamine</td>
                                        <td>1 mg/kg IV over 30-60 seconds</td>
                                        <td>Analgesic and Sedative</td>
                                        <td>Onset 1 min; Peak effect 1 min</td>
                                        <td>5-10mins</td>
                                        <td>Laryngospasm (0.3%), hyper salivation, vomiting, emergence reaction</td>
                                        <td>Ketamine is preferred for patients with hemodynamic instability or renal insufficiency.</td>
                                    </tr>
                                    <tr>
                                        <td>Fentanyl</td>
                                        <td>0.5-3 µg/kg IV over 3-5 mins</td>
                                        <td>Analgesic</td>
                                        <td>Immediate onset, Peak effect 2-3 mins</td>
                                        <td>30-45mins</td>
                                        <td>Chest wall rigidity and respiratory depression may occur with rapid IV administration</td>
                                        <td>Fentanyl is preferred for a rapid onset of analgesia in acutely distressed patients.</td>
                                    </tr>
                                    <tr>
                                        <td>Midazolam</td>
                                        <td>0.05-0.15 mg/kg IV</td>
                                        <td>Sedative</td>
                                        <td>Onset 3-5 mins; Peak effect 15-30 mins</td>
                                        <td>20-60mins</td>
                                        <td>Respiratory depression, hypotension</td>
                                        <td>Midazolam has a rapid onset and short duration and is classed as an ultra-short acting benzodiazepine and is 2 to 3 times more potent than diazepam, so can produce significant respiratory depression. Blood pressure decreases, and heart rate increases as compensation for a decreased SVR, although CO remains unchanged.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        
                        <div class="content-card">
                            <h4>Emergency Department Procedural Sedation and Analgesia Physician Checklist</h4>
                            <p>[patient label]</p>
                            <h5>Pre-Procedure Assessment</h5>
                            <p>
                                ☐ Past medical history (note history of OSA)<br>
                                ☐ Prior problems with sedation/anesthesia ______<br>
                                ☐ Allergies to food or medications<br>
                                ☐ Procedure<br>
                                ☐ Dentures none / upper / lower [should remain in during PSA unless intubation required]<br>
                                ☐ Cardiorespiratory reserve no or mild impairment / moderate impairment / significant impairment<br>
                                ☐ Difficult airway features none / mild concern / significant concern<br>
                                ☐ Last oral intake (see fasting grid on reverse) ______<br>
                                ☐ Will delay procedure until ______<br>
                                ☐ Weight (kg) ______<br>
                                ☐ Benefits of proceeding with PSA exceed risks
                            </p>
                            <h5>Difficult Airway Features</h5>
                            <p><strong>Difficult Laryngoscopy:</strong><br>
                            Look externally, Evaluate 3-3-2 rule, Mallampati score, Obstruction, Neck Mobility<br>
                            <strong>Difficult BVM Ventilation:</strong><br>
                            Beard, Obese, No teeth, Elderly, Sleep Apnea / Snoring<br>
                            <strong>Difficult LMA:</strong><br>
                            Restricted mouth opening, Obstruction, Distorted airway, Stiff lungs or c-spine<br>
                            <strong>Difficult Cricothyroidotomy:</strong> Surgery, Hematoma, Obesity, Radiation distortion or other deformity, Tumor*</p>
                            <p>☐ Is this patient a good candidate for ED procedural sedation and analgesia?<br>
                            The less cardiorespiratory reserve, the more difficult airway features, and the less procedural urgency, the more likely the patient should not receive PSA in the emergency department. If not a good candidate for ED-based PSA, other options include regional or local anesthetic; PSA or GA in the operating room; or endotracheal intubation in the ED.</p>
                            
                            <div style="display: flex; flex-wrap: wrap; gap: 1rem;">
                                <div style="flex: 1; min-width: 300px;">
                                    <h5>Pre-procedure Preparation</h5>
                                    <p>
                                        ☐ Analgesia - maximal patient comfort prior to PSA<br>
                                        ☐ Informed consent for PSA and procedure<br>
                                        ☐ Patient on monitor: telemetry, NIBP, SpO2, EtCO2<br>
                                        ☐ Oxygenate with NC O2 and high flow face mask O2<br>
                                        ☐ Select and draw up PSA agent(s)<br>
                                        ☐ Reversal agents and paralytic vials at bedside<br>
                                        ☐ Prepare for endotracheal intubation
                                    </p>
                                </div>
                                <div style="flex: 1; min-width: 300px;">
                                    <h5>Airway Equipment</h5>
                                    <p>
                                        ☐ Ambu bag connected to oxygen<br>
                                        ☐ Laryngoscopy handles and blades<br>
                                        ☐ Suction, oral & nasal airways<br>
                                        ☐ Endotracheal tubes & stylets<br>
                                        ☐ LMA with lubricant and syringe<br>
                                        ☐ Colorimetric capnometer<br>
                                        ☐ Bougie & difficult airway equipment
                                    </p>
                                </div>
                            </div>

                            <div class="table-container">
                                <table class="content-table">
                                    <thead><tr><th>Agent</th><th>Dose*</th><th>Contraindications</th><th>Comments</th></tr></thead>
                                    <tbody>
                                        <tr><td>Ketamine</td><td>1-2 mg/kg IV over 30-60 sec or 4-5 mg/kg IM, repeat half dose prn</td><td>Absolute: age < 3 months, schizophrenia<br>Relative: major posterior oropharynx procedures; history of airway instability, tracheal surgery, or tracheal stenosis; active pulmonary infection or disease; cardiovascular disease; CNS masses, abnormalities, or hydrocephalus</td><td>Preferred for longer procedures; avoid if hypertension/ tachycardia is a concern; have midazolam available to manage emergence distress; muscle tone is preserved or increased; post-procedure emesis may be mitigated by prophylactic ondansetron</td></tr>
                                        <tr><td>Etomidate</td><td>0.1-0.15 mg/kg IV, then 0.05 mg/kg q2-3 min prn</td><td></td><td>Intra-procedure myoclonus or hypertonicity, as well as post-procedure emesis, are common</td></tr>
                                        <tr><td>Fentanyl</td><td>1-2 mcg/kg IV, then 1 mcg/kg q3-5 min prn</td><td></td><td>Comparatively delayed onset of action; do not re-dose too quickly</td></tr>
                                        <tr><td>Midazolam</td><td>.05 mg/kg IV, then .05 mg/kg q3-5 min prn</td><td>Pregnancy, allergy to benzyl alcohol</td><td>Comparatively delayed onset of action; do not re-dose too quickly</td></tr>
                                        <tr><td>Pentobarbital</td><td>1 mg/kg IV, then 1 mg/kg q3-5 min prn</td><td>Pregnancy, porphyria</td><td>Use for painless procedures where analgesia is not needed</td></tr>
                                        <tr><td><strong>Reversal Agent</strong></td><td><strong>Dose</strong></td><td colspan="2"><strong>Caution</strong></td></tr>
                                        <tr><td>Naloxone</td><td>0.01-0.1 mg/kg IV or IM (typical adult dose 0.4 mg), max 2 mg</td><td colspan="2"></td></tr>
                                        <tr><td>Flumazenil</td><td>0.01 mg/kg IV (typical adult dose 0.2 mg) over 20 seconds, max 1 mg</td><td colspan="2">Only use in benzodiazepine naïve patient</td></tr>
                                    </tbody>
                                    <tfoot><tr><td colspan="4"><small>*All doses should be reduced in the elderly and in patients with marginal hemodynamics</small></td></tr></tfoot>
                                </table>
                            </div>
                            
                            <div style="display: flex; flex-wrap: wrap; gap: 1rem; align-items: flex-start;">
                                <div style="flex: 1; min-width: 250px;">
                                    <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-76-1.jpg" alt="Illustration of jaw thrust maneuver." class="content-image">
                                </div>
                                <div style="flex: 2; min-width: 300px;">
                                    <h5>PSA Intervention Sequence</h5>
                                    <ul>
                                        <li>Proceed down intervention sequence as slowly as patient condition permits</li>
                                        <li>Jaw thrust as illustrated above - thumbs on maxilla, four fingers posterior to ramus</li>
                                        <li>Laryngospasm notch is behind the earlobe, between mastoid process and condyle of mandible - bilateral, firm pressure medially and cephalad (up and in)</li>
                                        <li>If rescue ventilation is required, bag slowly and gently</li>
                                        <li>see emupdates.com/psa for details</li>
                                    </ul>
                                    <p>Detect hypoventilation early → Stop the drugs → Position the patient → Jaw thrust → Suction if needed → Laryngospasm notch pressure → Nasal airways → Consider reversal agents → Bag mask or LMA ventilation → Oral airway, ventilation → Intubate</p>
                                </div>
                            </div>

                            <h5>Post-procedure Assessment</h5>
                            <p>
                                ☐ Adverse events: none / hypoxia (< 90%) / aspiration / hypotension / agitation / other: ______<br>
                                ☐ Interventions taken: none / bag valve mask / LMA / ETT / reversal agent / hypotension Rx / admission for PSA / other: ______<br>
                                ☐ Adequacy of PSA: nondistressed / mild distress / severe distress<br>
                                ☐ Procedure: successful / unsuccessful
                            </p>
                            <h5>Fasting Grid</h5>
                            <p><small>**Green, Roback et al. Fasting and Emergency Department Procedural Sedation and Analgesia: A Consensus-Based Clinical Practice Advisory. Ann Emerg Med. 2007;49:454-461.</small></p>
                            <!-- Fasting grid tables would go here -->
                        </div>
                    </div>
                </section>
                <!-- END: algo45 -->
                
                <!-- START: analgesia-chart -->
                <section id="analgesia-chart" class="content-section" aria-labelledby="section-heading-analgesia">
                    <h2 id="section-heading-analgesia" class="section-heading">
                        <span class="heading-text">Analgesia Chart</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                           <table class="content-table">
                              <thead>
                                 <tr>
                                    <th>Drug</th>
                                    <th>Dosage</th>
                                    <th>Equianalgesic dose</th>
                                    <th>Onset/Peak Effect</th>
                                    <th>Duration of Action</th>
                                    <th>Adverse Effects</th>
                                    <th>Comments/Caveats</th>
                                 </tr>
                              </thead>
                              <tbody>
                                 <tr>
                                    <td>Morphine</td>
                                    <td>IV - 0.1 mg/kg; max. 0.3 mg/kg<br>SC - 0.1-0.2 mg/kg</td>
                                    <td>10 mg</td>
                                    <td>IV - Onset 3-5 mins; Peak effect 15-30 mins<br>SC - Onset 15-30 mins</td>
                                    <td>IV - 3-4 hrs<br>SC - 4 hrs</td>
                                    <td>Respiratory depression<br>Hypotension partly due to histamine release</td>
                                    <td>Acute severe pain (trauma) or persistent pain. Morphine is better preferred for obstetric pain.</td>
                                 </tr>
                                 <tr>
                                    <td>Fentanyl</td>
                                    <td>IV - 0.5-3 µg/kg over 3-5 mins</td>
                                    <td>100 µg</td>
                                    <td>IV - Immediate onset, Peak effect 2-3 mins<br>SC - Onset 7-15 mins</td>
                                    <td>IV - 30-45 mins<br>SC - 1-2 hrs</td>
                                    <td>Chest wall rigidity and respiratory depression may occur with rapid IV administration</td>
                                    <td>Acute severe pain. (trauma)<br>Fentanyl is preferred for a rapid onset of analgesia in acutely distressed patients. Fentanyl is preferred for patients with hemodynamic instability or renal insufficiency</td>
                                 </tr>
                                 <tr>
                                    <td>Pethidine</td>
                                    <td>IV - 0.5-1 mg/kg<br>SC - 1-2 mg/kg</td>
                                    <td>75 mg</td>
                                    <td>IV - 1-3 mins<br>SC - 30-90 mins</td>
                                    <td>IV - 2-4 hrs<br>SC - 3-4 hrs</td>
                                    <td>High doses may cause respiratory depression, agitation, muscle fasciculations, seizures or histamine induced hypotension</td>
                                    <td>Moderate-to-severe pain (migraine, trauma, acute abdominal pain)<br>It may be used in obstetric practice to relieve labour pain. Pethidine has an analgesic potency approximately equal to one-fifth that of morphine. Pethidine has an active metabolite (nor-meperidine) that causes neuro excitation and may interact with antidepressants, so it is NOT RECOMMENDED for repetitive use. It is also highly addictive.</td>
                                 </tr>
                                 <tr>
                                    <td>Tramadol</td>
                                    <td>IV/SC - 50-100 mg over 3-5 mins<br>Max 400 mg/d</td>
                                    <td>80 mg</td>
                                    <td>IV/SC - 45 mins</td>
                                    <td>IV/SC - 9-10 hrs</td>
                                    <td>> 400 mg/d are associated with an increased risk of seizures.</td>
                                    <td>Moderate-to-severe pain.<br>Tramadol is 5 to 10 times less potent than morphine. There is consequently an absence of respiratory depression, a low sedative effect, and less potential for dependence. There is a high incidence of nausea and vomiting. Slow administration over 3-5 minutes decreases the incidence of nausea and vomiting. Tramadol does not promote the release of histamine.</td>
                                 </tr>
                                 <tr>
                                    <td>Paracetamol</td>
                                    <td>IV - 15 mg/kg</td>
                                    <td>-</td>
                                    <td>IV - 15 mins (at end of infusion)</td>
                                    <td>IV - 4hrs</td>
                                    <td></td>
                                    <td>Mild-to-moderate pain<br>Can be used to supplement opioid analgesics</td>
                                 </tr>
                                 <tr>
                                    <td>Diclofenac</td>
                                    <td>IV -75 mg<br>IM -75 mg</td>
                                    <td>-</td>
                                    <td>IV - 5-10 mins<br>IM -15 mins</td>
                                    <td>IV - 6-8 hrs<br>IM - 6-8hrs</td>
                                    <td>- Gastrointestinal bleeding<br>- Bleeding secondary to platelet inhibition, and<br>- Development of renal insufficiency</td>
                                    <td>Mild-to-moderate pain.<br>Can be used to supplement opioid analgesics e.g. renal colic. All NSAIDs elevate SBP (median 5 mmHg). Patients with hypovolemia or hypo perfusion, the elderly, and those with preexisting renal impairment may be more susceptible to NSAID-induced renal injury.</td>
                                 </tr>
                              </tbody>
                              <tfoot>
                                  <tr>
                                      <td colspan="7">IM administration is generally NOT RECOMMENDED due to its multiple disadvantages: Painful administration, Unpredictable absorption, Complications involving tissue fibrosis and abscesses, and Rapid declines in analgesic effect. Subcutaneous (SC) administration provides similar pharmacokinetics with greater patient comfort. The SC route should replace the IM route for opioids.</td>
                                  </tr>
                              </tfoot>
                           </table>
                        </div>
                    </div>
                </section>
                <!-- END: analgesia-chart -->

                <!-- START: oxygen -->
                <section id="oxygen" class="content-section" aria-labelledby="section-heading-oxygen">
                    <h2 id="section-heading-oxygen" class="section-heading">
                        <span class="heading-text">Oxygen Prescription</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical guideline is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this guideline does not represent a breach of the standard of care.</p>
                        <img src="../assets/images/2025_09_24_e845fd66d8b7ec460a65g-78-1.jpg" alt="Oxygen prescription flowchart, guiding clinicians on when to start oxygen, target saturation levels, and choice of delivery device." class="content-image">
                        <p>Oxygen is a treatment for hypoxaemia, not breathlessness. Oxygen has not been proven to have any consistent effect on the sensation of breathlessness in non-hypoxemic patients.</p>
                        
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 1 Critical illness requiring high levels of supplemental oxygen</caption>
                                <tbody>
                                    <tr>
                                        <td>
                                            The initial oxygen therapy is a reservoir mask at 15 L/min pending the availability of reliable oximetry readings. For patients with spontaneous circulation and a reliable oximetry reading, it may quickly become possible to reduce the oxygen dose while maintaining a target saturation range of 94-96%. If oximetry is unavailable, continue to use a reservoir mask until definitive treatment is available. Patients with COPD and other risk factors for hypercapnia who develop critical illness should have the same initial target saturations as other critically ill patients pending the results of blood gas results after which these patients may need controlled oxygen therapy with target range 88-92% or supported ventilation if there is severe hypoxaemia and/or hypercapnia with respiratory acidosis.
                                        </td>
                                    </tr>
                                    <tr>
                                        <td>
                                            <strong>Additional Comments</strong><br>
                                            <strong>Cardiac arrest or resuscitation:</strong> Refer to resuscitation guidelines for choice of delivery device during active resuscitation. Give the highest possible inspired oxygen concentration during CPR until spontaneous circulation has been restored.<br>
                                            <strong>Shock, sepsis, major trauma, drowning, anaphylaxis, major pulmonary haemorrhage, status epilepticus:</strong> Also give specific treatment for the underlying condition.<br>
                                            <strong>Major head injury:</strong> Early tracheal intubation and ventilation if comatose.<br>
                                            <strong>Carbon monoxide poisoning:</strong> Give as much oxygen as possible using a bag-valve mask or reservoir mask. Check carboxyhaemoglobin levels. A normal or high oximetry reading should be disregarded because saturation monitors cannot differentiate between carboxyhaemoglobin and oxyhaemoglobin. The blood gas PO2 will also be normal in these cases (despite the presence of tissue hypoxia).
                                        </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 2 Serious illnesses requiring moderate levels of supplemental oxygen if the patient is hypoxaemic</caption>
                                <tbody>
                                    <tr>
                                        <td>
                                            The initial oxygen therapy is nasal cannulae at 2-6 L/min (preferably) or simple face mask at 5-10 L/min unless stated otherwise. For patients not at risk of hypercapnic respiratory failure who have saturation below 85%, treatment should be started with a reservoir mask at 15 L/min and the recommended initial oxygen saturation target range is 94-96%. If oximetry is not available, give oxygen as above until oximetry or blood gas results are available. Change to reservoir mask if the desired saturation range cannot be maintained with nasal cannulae or simple face mask. If these patients have coexisting COPD or other risk factors for hypercapnic respiratory failure, aim at a saturation of 88-92% pending blood gas results but adjust to 94-96% if the PCO2 is normal.
                                        </td>
                                    </tr>
                                    <tr>
                                       <td>
                                           <strong>Additional Comments</strong><br>
                                           <strong>Acute hypoxaemia (cause not yet diagnosed):</strong> Reservoir mask at 15 L/min if initial SpO2 below 85%, otherwise nasal cannulae or simple face mask. Patients requiring reservoir mask therapy need urgent clinical assessment by senior staff.<br>
                                           <strong>Pneumothorax:</strong> Needs aspiration or drainage if the patient is hypoxemic. Use a reservoir mask at 15 L/min if admitted for observation. Aim at 100% saturation.<br>
                                           <strong>Pulmonary embolism:</strong> Most patients with minor pulmonary embolism are not hypoxemic and do not require oxygen therapy.<br>
                                           <strong>Acute heart failure:</strong> Consider CPAP or NIV in cases of pulmonary oedema.<br>
                                           <strong>Severe anaemia:</strong> The main issue is to correct the anaemia. Most anaemic patients do not require oxygen therapy.
                                       </td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        
                        <div class="table-container">
                           <table class="content-table">
                               <caption>Table 3 Conditions for which patients should be monitored closely but oxygen therapy is not required unless the patient is hypoxemic</caption>
                               <tbody>
                                   <tr>
                                       <td>
                                           If hypoxemic, the initial oxygen therapy is nasal cannulae at 2-6 L/min or simple face mask at 5-10 L/min unless saturation is below 85% (use reservoir mask) or if at risk from hypercapnia. The recommended initial target saturation range, unless stated otherwise, is 94-96%. If patients have COPD or other risk factors for hypercapnic respiratory failure, aim at a saturation of 88-92%.
                                       </td>
                                   </tr>
                                   <tr>
                                       <td>
                                           <strong>Additional Comments</strong><br>
                                           <strong>Myocardial infarction and acute coronary syndromes:</strong> Most patients are not hypoxemic. Unnecessary use of high concentration oxygen may increase infarct size. Do not initiate oxygen therapy in patients with SpO2 ≥ 90%.<br>
                                           <strong>Stroke:</strong> Most patients with stroke are not hypoxemic. Oxygen therapy may be harmful for non-hypoxemic patients. Do not initiate oxygen therapy in patients with SpO2 ≥ 90%.<br>
                                           <strong>Hyperventilation or dysfunctional breathing:</strong> Exclude organic illness. Rebreathing from a paper bag may cause hypoxaemia and is not recommended.<br>
                                           <strong>Most poisonings and drug overdoses:</strong> Hypoxaemia is more likely with respiratory depressant drugs, give antidote if available. Check blood gases.<br>
                                           <strong>Pregnancy and obstetric emergencies:</strong> Oxygen therapy may be harmful to the foetus if the mother is not hypoxemic.
                                       </td>
                                   </tr>
                               </tbody>
                           </table>
                        </div>

                        <h4>Oxygen Delivery Devices</h4>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr><th>Device</th><th>Flow Rates</th><th>FiO<sub>2</sub></th><th>How to Titrate</th><th>Notes</th></tr>
                                </thead>
                                <tbody>
                                    <tr><td>Low-flow nasal cannula</td><td>1-6 L/min</td><td>Each L/min adds ~4% FiO<sub>2</sub> above room air*<br>1 L/min = 24% ... 6 L/min = 44%</td><td>Titrate flow rate only</td><td>Best for patients with normal respiratory rates and tidal volumes</td></tr>
                                    <tr><td>Simple face mask</td><td>~6-12 L/min</td><td>35-60%*</td><td>Titrate flow rate only</td><td>Minimum of 6 L/min flow is required to prevent rebreathing CO<sub>2</sub></td></tr>
                                    <tr><td>Non-rebreather mask</td><td>10-15 L/min</td><td>100%</td><td>Nontitratable</td><td>Short term bridge therapy only</td></tr>
                                    <tr><td>High Flow Nasal Cannula</td><td>Up to 60L/min</td><td>30-100%</td><td>Titrate flow rate and FiO<sub>2</sub></td><td>Administers PEEP with high flow rate</td></tr>
                                </tbody>
                            </table>
                            <p><small>*varies based on respiratory rate and minute ventilation</small></p>
                        </div>

                        <h4>Equipment used to deliver emergency oxygen therapy;</h4>
                        <ul>
                            <li>Humidification is not required for the delivery of low-flow oxygen or for the short-term use of high-flow oxygen. It is reasonable to use humidified oxygen for patients who require high-flow oxygen systems for >24 h or who report upper airway discomfort due to dryness.</li>
                            <li>In the emergency situation humidified oxygen use can be confined to patients with tracheostomy or an artificial airway.</li>
                            <li>Humidification may also be of benefit to patients with viscous secretions causing difficulty with expectoration. This benefit can be achieved using nebulised normal saline.</li>
                            <li>Bubble bottles should not be used because there is no evidence of clinically significant benefit but there is a risk of infection.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: oxygen -->

                <!-- START: acid-base -->
                <section id="acid-base" class="content-section" aria-labelledby="section-heading-acid-base">
                    <h2 id="section-heading-acid-base" class="section-heading">
                        <span class="heading-text">Acid-Base Disorders Worksheet</span>
                    </h2>
                    <div class="content-card">
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        <p><strong>Step #1: Gather the necessary data</strong> (Na<sup>+</sup>, Cl<sup>-</sup>, HCO<sub>3</sub><sup>-</sup>, pH, PCO<sub>2</sub>)<br>Preferably, all obtained from the same blood sample</p>
                        <p><strong>Step #2: Look at the pH</strong><br>If pH > 7.4 → the patient has a primary alkalosis → proceed to Step 3a<br>If pH < 7.4 → the patient has a primary acidosis → proceed to Step 3b</p>
                        <p><strong>Step #3: Look at the pCO<sub>2</sub></strong><br>3a: If pCO<sub>2</sub> > 40 → patient's alkalosis is metabolic<br>If pCO<sub>2</sub> < 40 → patient's alkalosis is respiratory<br>3b: If pCO<sub>2</sub> > 40 → patient's acidosis is respiratory<br>If pCO<sub>2</sub> < 40 → patient's acidosis is metabolic</p>
                        <p><strong>Step #4: Look for disorders revealed by failures of compensation</strong></p>
                        <ul>
                           <li>If primary process is metabolic alkalosis → pCO<sub>2</sub> should be > 40 but < 55*<br><small>*There are several metabolic alkalosis PCO2 prediction formulas, but fraught with clinical inaccuracy/unreliability</small></li>
                           <li>If primary process is metabolic acidosis → calculate predicted pCO<sub>2</sub> = (1.5 × HCO<sub>3</sub><sup>-</sup>) + 8 ± 2</li>
                        </ul>
                        <p>In either case above: If actual pCO<sub>2</sub> is too high → there is an additional respiratory acidosis. If actual pCO<sub>2</sub> is too low → there is an additional respiratory alkalosis.<br>If primary process is respiratory → skip to Steps 5 & 6</p>
                        <p><strong>Step #5: Check if the patient has a significant Anion Gap (>12-18)</strong> (AG = Na<sup>+</sup> - Cl<sup>-</sup> - HCO<sub>3</sub><sup>-</sup>)<br>If AG is significantly elevated → the patient has an anion gap metabolic acidosis.</p>
                        <p><strong>Step #6: Calculate the corrected HCO<sub>3</sub><sup>-</sup></strong> (AG - 12 + HCO<sub>3</sub><sup>-</sup>)<br>If corrected HCO<sub>3</sub><sup>-</sup> > 30 → the patient has an underlying metabolic alkalosis<br>If corrected HCO<sub>3</sub><sup>-</sup> < 23 → the patient has an underlying non-AG metabolic acidosis</p>
                        
                        <p><strong>Step #7: Make a diagnosis(es) using the differentials below and knowledge of the patient</strong></p>
                        <div class="table-container">
                            <table class="content-table">
                               <thead>
                                  <tr>
                                     <th colspan="2">Metabolic Acidosis</th>
                                     <th rowspan="2">Metabolic Alkalosis</th>
                                     <th colspan="2">Respiratory</th>
                                  </tr>
                                  <tr>
                                     <th>Anion Gap</th>
                                     <th>Non-Anion Gap</th>
                                     <th>Acidosis (Acute)</th>
                                     <th>Alkalosis</th>
                                  </tr>
                               </thead>
                               <tbody>
                                  <tr>
                                     <td>"MUDPILERS"</td>
                                     <td>"HARDUPS"</td>
                                     <td>"CLEVER PD"</td>
                                     <td rowspan="9">Anything that causes hypoventilation:<br>CNS depression (CVA/Drugs)<br>Airway obstruction<br>Pneumonia<br>Pulmonary oedema<br>Haemo/Pneumothorax<br>Myopathy<br><br>Chronic respiratory acidosis is caused by COPD and restrictive lung disease</td>
                                     <td rowspan="9">Anything that causes hyperventilation:<br>CNS disease<br>Hypoxia<br>Anxiety<br>Mechanical ventilation<br>Progesterone<br>Salicylates/Sepsis</td>
                                  </tr>
                                  <tr><td>Methanol</td><td>Hyperalimentation</td><td>Contraction</td></tr>
                                  <tr><td>Uraemia</td><td>Acetazolamide</td><td>Liquorice*</td></tr>
                                  <tr><td>Diabetic/Alcoholic/Starvation Keto Acidosis</td><td>Renal tubular acidosis</td><td>Endocrine: Conns / Cushing's / Bartter's)*</td></tr>
                                  <tr><td>Paraldehyde</td><td>Diarrhoea</td><td>Vomiting, NG suction</td></tr>
                                  <tr><td>Isoniazid/ Iron toxicity</td><td>Uretero-Pelvic shunt</td><td>Excess alkali*</td></tr>
                                  <tr><td>Lactic acidosis</td><td>Post-hypocapnia</td><td>Refeeding alkalosis*</td></tr>
                                  <tr><td>Ethanol / Ethylene Glycol</td><td>Spironolactone</td><td>Post-hypercapnia</td></tr>
                                  <tr><td>Rhabdomyolysis/Renal Failure</td><td></td><td>Diuretics*</td></tr>
                                  <tr><td>Salicylates</td><td></td><td><small>*associated with high urine Cl- levels</small></td><td></td><td></td></tr>
                               </tbody>
                            </table>
                         </div>
                         <p><strong>Step #8: Fix it!</strong></p>
                    </div>
                </section>
                <!-- END: acid-base -->

                <!-- START: paediatric -->
                <section id="paediatric" class="content-section" aria-labelledby="section-heading-paediatric">
                    <h2 id="section-heading-paediatric" class="section-heading">
                        <span class="heading-text">Paediatric Emergency Reference Guide</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Age</th>
                                        <th>Length (cm)</th>
                                        <th>Weight (Kg)</th>
                                        <th>Pulse Rate</th>
                                        <th>Resp Rate</th>
                                        <th>Systolic BP mmHg</th>
                                        <th>Diastolic BP mmHg</th>
                                        <th>Temp (°C)</th>
                                        <th>ET Size (mm)</th>
                                        <th>ET Depth (cm)</th>
                                        <th>Laryngoscope Blade</th>
                                        <th>LMA</th>
                                        <th>NG Tube</th>
                                        <th>Suction Catheter</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr><td>Preterm</td><td>&lt; 50</td><td>1-2</td><td>100-180</td><td>40-60</td><td>30-50</td><td>35-45</td><td>34.0-38.0</td><td>2.5</td><td>6+WT</td><td>0</td><td>1</td><td>5</td><td>5-6</td></tr>
                                    <tr><td>Term New-born</td><td>50</td><td>3-4</td><td>100-180</td><td>40-60</td><td>60-90</td><td>40-45</td><td>34.0-38.0</td><td>3.0</td><td>6+WT</td><td>1</td><td>1</td><td>5-8</td><td>6-8</td></tr>
                                    <tr><td>6 months</td><td>67</td><td>7</td><td>100-160</td><td>30-60</td><td>83-105</td><td>40-45</td><td>34.0-38.0</td><td>3.5</td><td>11</td><td>1</td><td>1.5</td><td>8</td><td>8</td></tr>
                                    <tr><td>1 year</td><td>75</td><td>10</td><td>80-110</td><td>26-34</td><td>95-105</td><td>50-65</td><td>34.0-38.0</td><td>4.0</td><td>11-12</td><td>1</td><td>2</td><td>10</td><td>8-10</td></tr>
                                    <tr><td>3 years</td><td>95</td><td>15</td><td>70-110</td><td>24-26</td><td>96-110</td><td>55-75</td><td>36.1-37.8</td><td>4.5</td><td>13-14</td><td>2</td><td>2</td><td>10</td><td>10</td></tr>
                                    <tr><td>5 years</td><td>110</td><td>18</td><td>65-110</td><td>20-24</td><td>96-110</td><td>55-75</td><td>36.1-37.8</td><td>5.0</td><td>14-15</td><td>2</td><td>2</td><td>12</td><td>10</td></tr>
                                    <tr><td>6 years</td><td>115</td><td>20</td><td>65-110</td><td>20-24</td><td>97-112</td><td>65-80</td><td>36.1-37.8</td><td>5.5</td><td>15-16</td><td>2</td><td>2.5</td><td>12</td><td>10</td></tr>
                                    <tr><td>8 years</td><td>127</td><td>25</td><td>65-110</td><td>20-24</td><td>97-112</td><td>65-80</td><td>36.1-37.8</td><td>6.0</td><td>17-18</td><td>2</td><td>3</td><td>14</td><td>10</td></tr>
                                    <tr><td>12 years</td><td>150</td><td>40</td><td>60-100</td><td>12-20</td><td>112-128</td><td>70-85</td><td>35.9-37.6</td><td>6.5</td><td>19-20</td><td>3</td><td>3-4</td><td>14</td><td>12</td></tr>
                                    <tr><td>16 years</td><td>&gt; 150</td><td>&gt; 50</td><td>60-100</td><td>12-20</td><td>112-128</td><td>70-85</td><td>35.9-37.6</td><td>7.0</td><td>20-24</td><td>3</td><td>3-4</td><td>18</td><td>12</td></tr>
                                </tbody>
                                <tfoot>
                                    <tr><td colspan="14">Appropriate internal diameter (mm) of ET Tube = (Age in years/4) + 4; NB: ET tube size, choose a size larger and a size smaller in addition to the indicated size.<br>Appropriate length of Oral tube (cm) = New-born = 6 + weight (Kg); in infant and child = (Age in years/2) + 12 or three times the internal tube diameter<br>Appropriate length of Nasal tube (cm) = (Age in years/2) + 15</td></tr>
                                </tfoot>
                            </table>
                        </div>
                        <p><strong>Adrenaline</strong><br>New-born: 0.1-0.3 mL/Kg of 1:10,000 IV/IO<br>Child: 0.1 mL/Kg of 1:10,000 IV/IO; 0.1 mL/Kg of 1:1,000 ET</p>
                        <!-- Adrenaline dose table, other drugs, fluid challenge, defibrillation, cardioversion -->
                        <p><strong>Noradrenaline:</strong> 0.02-0.1 µg/Kg/min, titrated to effect</p>
                        <p><strong>Ketamine (to be used with Atropine to counter hypersalivation):</strong> 1-2 mg/Kg IV. Effect lasts 4-5 mins and there is need to combine with another sedative.</p>
                        <p><strong>Atropine:</strong> 0.02 mg/Kg IV/IO or ET (MINIMUM DOSE = 0.1 mg; MAX SINGE DOSE = 0.5 mg for child and 1 mg for adolescent) may repeat x1</p>
                        <p><strong>Midazolam:</strong> IV 0.1-0.2 mg/Kg. Onset of action in 3-5 minutes, peak action 3-5 minutes and duration of action up to 60 minutes</p>
                        <p><strong>Rocuronium:</strong> IV 0.6-1.2 mg/Kg. Onset of action in 30-60 seconds and duration of action 30-40 minutes</p>
                        <p><strong>Fentanyl:</strong> IV 1-4 µg/Kg. Onset of action in 2-3 minutes, peak action 3-4minutes and duration of action 20-60 minutes</p>
                        <p><strong>Morphine PO,SC,IV</strong><br>Neonates: 50-100 µg/Kg every 6 hours, adjusted according to response<br>Child: 100-200 µg/Kg every 4-6 hours, adjusted according to response. IV or SC infusion: 10-30 µg/Kg/hr adjusted according to response.</p>
                        <p><strong>Lidocaine:</strong> 1 mg/Kg IV/IO/ET; follow by an infusion.</p>
                        <p><strong>Adenosine:</strong> 0.1 mg/Kg rapid IV/IO push; increase to 0.2 mg/Kg if needed; MAXIMUM SINGE DOSE = 12 mg</p>
                        <p><strong>Amiodarone:</strong> 5 mg/Kg IV/IO ; rapid bolus for pulseless VT/VF; over 20-60 min for perfusing. Tachycardia. MAXIMUM SINGLE DOSE: 300 mg . My repeat to MAX DOSE = 15 mg/Kg/Day (2.2 gm/Day). DO NOT combine with procainamide.</p>
                        <p><strong>Crystalloid Fluid Challenge in Shock</strong><br>Choose and ISOTONIC, non-glucose containing solution (Hartmann's solution/ Ringer's Lactate is preferred, use Normal Saline in its absence). Rapid IV Fluid Bolus.<br>New-born: 10 mL/Kg; infant or child: 20 mL/Kg; repeat as needed (after reassessment) up to three boluses. If no response after 3rd bolus, consult Pediatrician.</p>
                        <p><strong>Defibrillation:</strong> 1st shock 2 J/Kg, 2nd Shock 4 J/Kg. Subsequent Shocks ≥ 4 J/Kg MAXIMUM 10J/Kg or adult dose.</p>
                        <p><strong>Cardioversion:</strong> 0.5-1 J/Kg; if not effective, increase to 2 J/Kg.</p>
                    </div>
                </section>
                <!-- END: paediatric -->

                <!-- START: checklist -->
                <section id="checklist" class="content-section" aria-labelledby="section-heading-checklist">
                    <h2 id="section-heading-checklist" class="section-heading">
                        <span class="heading-text">Emergency Care Checklist</span>
                    </h2>
                    <div class="content-card">
                        <p>(Adapted from the WHO Medical & Trauma Checklist)</p>
                        <p>This clinical pathway is intended to supplement, rather than substitute for, professional judgment and may be changed depending upon a patient's individual needs. Failure to comply with this pathway does not represent a breach of the standard of care.</p>
                        
                        <h4>Immediately after primary & secondary surveys:</h4>
                        <ul>
                           <li>IS FURTHER AIRWAY INTERVENTION NEEDED? ☐ YES, DONE ☐ NO</li>
                           <li>IS THERE A TENSION PNEUMO-THORAX?* ☐ YES, CHEST DRAIN PLACED ☐ NO</li>
                           <li>IS THE PULSE OXIMETER PLACED AND FUNCTIONING? ☐ YES ☐ NO ☐ NOT AVAILABLE</li>
                           <li>DOES THE PATIENT NEED OXYGEN (SPO2 < 94%) ? ☐ YES ☐ NO ☐ NOT AVAILABLE</li>
                           <li>LARGE-BORE IV PLACED AND FLUIDS/BLOOD TRANSFUSION STARTED? ☐ YES ☐ NOT INDICATED ☐ NOT AVAILABLE</li>
                           <li>HEAD-TO-TOE SURVEY FOR (AND CONTROL OF) EXTERNAL BLEEDING, INCLUDING:* ☐ SCALP ☐ PERINEUM ☐ BACK</li>
                           <li>ASSESS FOR PELVIC FRACTURE BY:* ☐ EXAM ☐ X-RAY ☐ CT-SCAN</li>
                           <li>ASSESS FOR INTERNAL BLEEDING BY:* ☐ EXAM ☐ ULTRASOUND (E-FAST) ☐ CT-SCAN</li>
                           <li>IS SPINAL IMMOBILIZATION NEEDED?* ☐ YES ☐ NOT INDICATED</li>
                           <li>RANDOM BLOOD SUGAR CHECKED ☐ YES ☐ NO</li>
                           <li>NEUROVASCULAR STATUS OF ALL 4 LIMBS CHECKED?* ☐ YES</li>
                           <li>IS THE PATIENT HYPOTHERMIC? ☐ YES, WARMING ☐ NO</li>
                           <li>DOES THE PATIENT NEED (IF NO CONTRAINDICATION)? ☐ URINARY CATHETER ☐ NASOGASTRIC TUBE ☐ CHEST DRAIN ☐ NONE INDICATED</li>
                        </ul>
                        <p><small>*associated with trauma but not specific</small></p>

                        <h4>Before TEAM leaves the patient's bedside:</h4>
                        <ul>
                           <li>HAS THE PATIENT BEEN GIVEN: ☐ TETANUS VACCINE ☐ ANALGESICS ☐ ANTIBIOTICS ☐ NONE INDICATED</li>
                           <li>HAVE ALL TESTS AND IMAGING BEEN REVIEWED? ☐ YES ☐ NO, FOLLOW-UP PLAN IN PLACE</li>
                           <li>WHICH SERIAL EXAMINATIONS ARE NEEDED? ☐ NEUROLOGICAL ☐ RESPIRATORY ☐ ABDOMINAL ☐ CARDIOVASCULAR ☐ NONE</li>
                           <li>PLAN OF CARE DISCUSSED WITH: ☐ PATIENT/FAMILY ☐ RECEIVING UNIT ☐ PRIMARY TEAM ☐ OTHER SPECIALISTS</li>
                           <li>RELEVANT EMERGENCY CARE CHART OR FORM COMPLETED? ☐ YES ☐ NOT AVAILABLE</li>
                        </ul>
                    </div>
                </section>
                <!-- END: checklist -->
                
                <!-- START: references -->
                <section id="references" class="content-section" aria-labelledby="section-heading-references">
                    <h2 id="section-heading-references" class="section-heading">
                        <span class="heading-text">References</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                           <li>Triage Clinical care for severe acute respiratory infection: toolkit. COVID-19 adaptation. Geneva: World Health Organization; 2020.</li>
                           <li>American Heart Association. 2020 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2020.</li>
                           <li>Campbell RL, et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 2014.</li>
                           <li>Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2022.</li>
                           <li>Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018.</li>
                           <li>Amsterdam EA, et al. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation. 2014.</li>
                           <li>2019 ESC Guidelines for the management of patients with supraventricular tachycardia. European Heart Journal. 2019.</li>
                           <li>Unger T, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020.</li>
                           <li>Powers WJ, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update. Stroke. 2019.</li>
                           <li>Fonseca AC, et al. European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack. European Stroke Journal. 2021.</li>
                           <li>Saccilotto RT, et al. San Francisco Syncope Rule to predict short-term serious outcomes: A systematic review. CMAJ 2011.</li>
                           <li>Hoffman JR, et al. Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. N Engl J Med. 2000.</li>
                           <li>Stiell IG, et al. The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA 2001.</li>
                           <li>Stiell IG, et al. The Canadian CT Head Rule for patients with minor head injury. Lancet 2001.</li>
                           <li>Van Ness-Otunnu R, Hack JB. Hyperglycemic crisis. J Emerg Med. 2013.</li>
                           <li>Evans LE, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine: 2021.</li>
                           <li>Suicide Prevention Resource Center. (2015). Caring for adult patients with suicide risk: A consensus guide for emergency departments.</li>
                           <li>Moayyedi PM, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017.</li>
                           <li>Chou R, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007.</li>
                        </ul>
                        <hr>
                        <p style="text-align: center;"><strong>EMERGENCY CARE ALGORITHMS ©</strong><br>
                        <a href="https://www.emergencymedicinekenya.org/algorithms">https://www.emergencymedicinekenya.org/algorithms</a></p>
                        <p>Test your emergency care knowledge with our exciting multiple-choice questions based on the latest edition of the Emergency Care Algorithms. To get a certificate of completion, you will need to complete all the MCQs with an average score of 75% for each quiz. You may take each quiz as many times as you want.</p>
                        <h4>Did You Know?</h4>
                        <p>The Constitution of Kenya (2010) and the Health Act (2017) guarantees you the right to emergency medical treatment. All public and private health facilities have a legal duty to provide you with emergency medical treatment. Any Health Institution that fails to provide emergency medical treatment despite having the capacity to do so, could face conviction and fines up to Ksh. 3 million.</p>
                        <p style="text-align: center;">
                            P.O. Box 1023 City Square 00200 Nairobi, Kenya<br>
                            Tel: +254 20 2100054/ +254 710633855<br>
                            Email: emkf@emkfoundation.org<br>
                            Visit us on the web:<br>
                            www.emergencymedicinekenya.org
                        </p>
                    </div>
                </section>
                <!-- END: references -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="08-psychiatric-gi-poisoning.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 100%;"></div>
                        </div>
                       <span class="progress-text">Part 9 of 9</span>
                    </div>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>